BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sokolova M, Yang K, Hansen SH, Louwe MC, Kummen M, Hov JER, Sjaastad I, Berge RK, Halvorsen B, Aukrust P, Yndestad A, Ranheim T. NLRP3 inflammasome deficiency attenuates metabolic disturbances involving alterations in the gut microbial profile in mice exposed to high fat diet. Sci Rep 2020;10:21006. [PMID: 33273482 DOI: 10.1038/s41598-020-76497-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Kazmi I, Sarim Imam S, Al-abbasi FA, Afzal M, Shahid Nadeem M, Alshehri S. Environment friendly green synthesis method based natural bioactive functional “catechin and gingerol” loaded nanomedicine for the management of obesity. International Journal of Pharmaceutics 2022;628:122340. [DOI: 10.1016/j.ijpharm.2022.122340] [Reference Citation Analysis]
2 Qiang R, Li Y, Dai X, Lv W. NLRP3 inflammasome in digestive diseases: From mechanism to therapy. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.978190] [Reference Citation Analysis]
3 Wang L, Wang S, Zhang Q, He C, Fu C, Wei Q. The role of the gut microbiota in health and cardiovascular diseases. Mol Biomed 2022;3:30. [PMID: 36219347 DOI: 10.1186/s43556-022-00091-2] [Reference Citation Analysis]
4 Sundaram SM, Doughty LA, Sereda MW. Location matters: hexokinase 1 in glucose metabolism and inflammation. Trends in Endocrinology & Metabolism 2022;33:665-667. [DOI: 10.1016/j.tem.2022.07.005] [Reference Citation Analysis]
5 Hildebrandt X, Ibrahim M, Peltzer N. Cell death and inflammation during obesity: “Know my methods, WAT(son)”. Cell Death Differ 2022. [DOI: 10.1038/s41418-022-01062-4] [Reference Citation Analysis]
6 Zafari N, Velayati M, Fahim M, Maftooh M, Pourali G, Khazaei M, Nassiri M, Hassanian SM, Ghayour-Mobarhan M, Ferns GA, Kiani MA, Avan A. Role of gut bacterial and non-bacterial microbiota in alcohol-associated liver disease: Molecular mechanisms, biomarkers, and therapeutic prospective. Life Sci 2022;:120760. [PMID: 35787997 DOI: 10.1016/j.lfs.2022.120760] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhang XN, Yu ZL, Chen JY, Li XY, Wang ZP, Wu M, Liu LT. The crosstalk between NLRP3 inflammasome and gut microbiome in atherosclerosis. Pharmacol Res 2022;:106289. [PMID: 35671922 DOI: 10.1016/j.phrs.2022.106289] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 De Jesus A, Keyhani-Nejad F, Pusec CM, Goodman L, Geier JA, Stoolman JS, Stanczyk PJ, Nguyen T, Xu K, Suresh KV, Chen Y, Rodriguez AE, Shapiro JS, Chang HC, Chen C, Shah KP, Ben-Sahra I, Layden BT, Chandel NS, Weinberg SE, Ardehali H. Hexokinase 1 cellular localization regulates the metabolic fate of glucose. Mol Cell 2022:S1097-2765(22)00166-6. [PMID: 35305311 DOI: 10.1016/j.molcel.2022.02.028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
9 Chang TT, Chen JW. Direct CCL4 Inhibition Modulates Gut Microbiota, Reduces Circulating Trimethylamine N-Oxide, and Improves Glucose and Lipid Metabolism in High-Fat-Diet-Induced Diabetes Mellitus. J Inflamm Res 2021;14:6237-50. [PMID: 34866923 DOI: 10.2147/JIR.S343491] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Li Y, Tian Y, Cai W, Wang Q, Chang Y, Sun Y, Dong P, Wang J. Novel ι-Carrageenan Tetrasaccharide Alleviates Liver Lipid Accumulation via the Bile Acid-FXR-SHP/PXR Pathway to Regulate Cholesterol Conversion and Fatty Acid Metabolism in Insulin-Resistant Mice. J Agric Food Chem 2021;69:9813-21. [PMID: 34415766 DOI: 10.1021/acs.jafc.1c04035] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
11 Bordoni L, Petracci I, Zhao F, Min W, Pierella E, Assmann TS, Martinez JA, Gabbianelli R. Nutrigenomics of Dietary Lipids. Antioxidants (Basel) 2021;10:994. [PMID: 34206632 DOI: 10.3390/antiox10070994] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
12 Martín-Mateos R, Albillos A. The Role of the Gut-Liver Axis in Metabolic Dysfunction-Associated Fatty Liver Disease. Front Immunol 2021;12:660179. [PMID: 33936094 DOI: 10.3389/fimmu.2021.660179] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 19.0] [Reference Citation Analysis]